Q4 2017 Holdings
Filed 2018-02-14 | 24 holdings | $146.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Coty Inc(COTY) | COM CL A | 222070203 | $142.1M | 7,143,872 | 97.1% |
| Cooper STD Hldgs Inc(CPS) | COM | 21676P103 | $2.4M | 19,879 | 1.7% |
| Spdr S&P 500 ETF TR(SPY)Call | TR UNIT | 78462F103 | $1.3M | 5,000,000 | 0.9% |
| Altaba Inc(AABAUSD) | COM | 021346101 | $238.1K | 3,408,587 | 0.2% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $45.5K | 2,245,000 | 0.0% |
| National GEN Hldgs Corp | COM | 636220303 | $22.8K | 1,162,500 | 0.0% |
| HRG Group Inc | COM | 40434J100 | $17.3K | 1,022,878 | 0.0% |
| Novagold RES Inc(NG) | COM NEW | 66987E206 | $16.6K | 4,234,129 | 0.0% |
| Stealthgas Inc(GASS) | SHS | Y81669106 | $16.2K | 3,708,819 | 0.0% |
| Tribune Media Co(TRCO) | CL A | 896047503 | $15.5K | 365,000 | 0.0% |
| Blueknight Energy Partners L(BKEPUSD) | COM UNIT | 09625U109 | $14.3K | 2,794,826 | 0.0% |
| Ziopharm Oncology Inc | COM | 98973P101 | $14.1K | 3,410,500 | 0.0% |
| Ishares Inc(EWJ)Call | MSCI JPN ETF NEW | 46434G822 | $12.2K | 204,000 | 0.0% |
| BMC STK Hldgs Inc(BMCH) | COM | 05591B109 | $12.2K | 482,088 | 0.0% |
| Marten Trans LTD(MRTN) | COM | 573075108 | $10.2K | 500,000 | 0.0% |
| JPMorgan Chase & Co(JPM) | COM | 46625H100 | $8.0K | 75,000 | 0.0% |
| Synthetic Biologics Inc | COM | 87164U102 | $2.1K | 4,118,402 | 0.0% |
| Egalet Corp | COM | 28226B104 | $1.0K | 1,040,009 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $577 | 30,000 | 0.0% |
| Fibrocell Science Inc | COM PAR | 315721308 | $443 | 692,960 | 0.0% |
| Oragenics Inc | COM NEW | 684023203 | $405 | 1,725,000 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $299 | 50,000 | 0.0% |
| Alps ETF TR(AMLPUSD)Call | ALERIAN MLP | 00162Q866 | $132 | 12,200 | 0.0% |
| Ampliphi Biosciences Corp | COM PAR | 03211P301 | $15 | 15,011 | 0.0% |